Adaptive Biotechnologies to receive up to $250M in financing deal
September 14, 2022 at 17:22 PM EDT
The Seattle-based biotech can tap three tranches of funding under an agreement with health care investment firm OrbiMed.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|